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Inhibition of basal and TGFJ-induced fibroblast collagen synthesis by
antineoplastic agents. Implications for wound healing
T. Hendriks, M.F.W.C. Martens, C.M.L.C. Huyben & T. Wobbes
Department ofGeneral Surgery, University Hospital Nijmegen, Nijmegen, The Netherlands.
Summary Antineoplastic drugs, given in the perioperative period, are thought to be a hazard to wound
repair. Since fibroblast collagen synthesis is crucial to healing, we examined the effects of bleomycin, cisplatin
and 5-fluorouracil on collagen synthesis in confluent cultures of fibroblasts from human colon and skin. The
drugs were added in final concentrations between 0.1 and 501M.
Bleomycin did not affect collagen synthesis in colon fibroblasts but inhibited synthesis in skin fibroblasts.
Collagen synthesis in colon fibroblasts was strongly, and specifically, inhibited by cisplatin while synthesis in
skin fibroblasts was affected only slightly. 5-Fluorouracil had no effect whatsoever on the collagen synthetic
capacity in either colon or skin fibroblasts. If skin fibroblasts were cultured in the presence of transforming
growth factor P (TGF1), the antineoplastic agents inhibited the TGF1-stimulated collagen synthesis at far
lower concentrations than those needed to suppress non-stimulated synthesis. This effect was not observed in
fibroblasts from colon.
The possible implications of these observations, as pertain to the use of perioperative chemotherapy, are
discussed. Since 5-fluorouracil did not directly affect collagen synthesis in colon fibroblasts under any of the
conditions tested it is suggested that the data support the contention that this drug is relatively harmless for
intestinal healing.
At present, surgery remains the only effective treatment
modality for patients with malignant gastro-intestinal
tumours. However, the occurrence of local and/or regional
recurrences constitutes a major problem in the management
of such patients. Recurrence rates may be reduced by anti-
neoplastic therapy. Adjuvant treatment for colorectal cancer
continues to centre on the use of 5-fluorouracil and regimens
that include 5-fluorouracil offer the greatest hope for patients
with this malignancy (Grem, 1991). It can be argued that the
most suitable time for such therapy would be during or
immediately after tumour-reducing surgery (Harris & Mas-
trangelo, 1991). Since it is generally accepted that most
antineoplastic agents used in the perioperative period will
impede tissue repair (Falcone & Nappi, 1984), the healing of
intestinal anastomoses appears to be at risk after administra-
tion of this class of compounds (Koruda & Rolandelli, 1990).
Indeed, studies from our laboratory have shown that a com-
bination of bleomycin, cisplatin and 5-fluorouracil, given
once a day over 5 consecutive days, severely impairs the
development of strength in experimental intestinal anasto-
moses constructed on the third day of the cytostatic regimen
(de Roy van Zuidewijn et al., 1986, 1991). In contrast,
administration of 5-fluorouracil alone appears to be less
detrimental (Hillan et al., 1988; de Waard et al., manuscript
in preparation).
The strength of the intact and the anastomosed bowel wall
is derived from collagen fibrils. Normal anastomotic healing
is characterized by a strongly enhanced collagen synthetic
activity (Jiborn et al., 1980; Martens & Hendriks, 1991). The
loss of strength encountered after administration of the cyto-
statics mixture mentioned above is attended by diminished
deposition of collagen in the wound area as a result of a
massive inhibition of the collagen synthetic capacity (Martens
et al., 1992a). Fibroblasts are the major source of newly-
formed collagen in a healing wound. Thus, inhibition of
wound collagen synthesis by antineoplastic agents may be the
result of their effects on fibroblasts chemotaxis and prolifera-
tion, either direct or indirect through effects on macrophages,
which cells play a pivotal regulatory role in the healing
sequence (Fukasawa et al., 1990). This way, the diminished
protein synthesis would simply be the result of a reduced
presence of fibroblasts in the wound area. In addition, these
drugs may directly affect fibroblast protein synthesis. Very
few studies are known which report on the specific effects of
antineoplastic agents on fibroblast collagen synthesis. We
have examined if, and to what extent, bleomycin, cisplatin
and 5-fluorouracil inhibit fibroblast collagen synthesis and if
these effects are specific for collagen. For this purpose, we
have used fibroblasts from both human colon and skin since
we found recently that collagen production in these cells may
react differently to various stimuli (Martens et al., in press).
We also investigated the effects of the three antineoplastic
agents on fibroblast collagen synthesis measured after addi-
tion of transforming growth factor P (TGF1). TGFP
enhances fibroblast collagen production (Ignotz & Massague,
1986) and, if applied topically, promotes wound healing
(Jones et al., 1991). Its intrinsic role in the repair process is
indicated by its transient and localised expression in healing
wounds (Cromack et al., 1987; Kane et al., 1991). Therefore,
interference with TGF1-induced fibroblast collagen synthesis
may seriously affect wound repair.
Materials and methods
Materials
All supplies for cell culture were purchased from Life Tech-
nologies (Breda, The Netherlands). The cytostatics used were
bleomycin (Lundbeck, Amsterdam, The Netherlands), cispla-
tin (Lederle, Etten-Leur, The Netherlands) and 5-fluorouracil
(Roche, Mijdrecht, The Netherlands). TGFPI from bovine
bone was a gift from Dr G. Ksander (Celtrix Labs, Palo
Alto, USA). L-[2,3-3H]Proline (1,63 TBq/mmol) and [6-3H]
thymidine (963 GBq mmol- ) were purchased from Amer-
sham International, England. Collagenase (type VII) was
obtained from Sigma (St. Louis, USA). All other reagents
were of analytical grade (Merck, Darmstadt, Germany).
Cell culture
Normal human colon fibroblasts (HCF) were obtained from
the American Type Culture Collection (CRL-1459). Human
skin fibroblasts (HSF) were obtained from explants of skin
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biopsies of a healthy adult. Both the HSF and HCF were
grown in Dulbecco's Modified Eagles Medium (DMEM)
supplemented with antibiotics (100 U ml-' penicillin and
100figml-' streptomycin) and 10% foetal calf serum (FCS)
at 37°C in a 5% C02, 95% air humidified atmosphere. Cells
were used between the third and tenth passage.
Assay offibroblast proliferation
Freshly trypsinised fibroblasts were plated in 96-well micro-
titre plates at a density of approximately 5 x 104 cells/well in
0.1 ml DMEM plus 10% FCS. After a 4 h incubation the
medium was replaced by 0.1 ml DMEM and the cells were
incubated for a further 18 h. Subsequently, the medium was
replaced again by 0.1 ml DMEM plus 10% FCS and incuba-
tion continued for another 48 h. At the end of this period
antineoplastic agents (10 j.l, dissolved in DMEM) were add-
ed, after 6 h followed by 0.5 iCi 3H-thymidine. After a final
incubation period of 18 h, the medium was removed and the
cells were trypsinised, harvested on a filter using a cell har-
vester (LKB Wallag) and the incorporation of thymidine was
counted.
Assay offibroblasts collagen production
Collagen production by steady state, visually confluent fibro-
blasts was assessed over a 24 h period by [3H]proline incor-
poration into collagenous protein.
Freshly trypsinised fibroblasts were plated in 6-well 9.6 cm2
tissue culture plates at a density of approximately 1.5 x 105
cells/well in 2 ml DMEM plus 10% FCS. Three days after
plating the medium was removed and replaced by the same
medium or with DMEM without serum. In the latter case the
wells were first washed twice with phosphate buffered saline
(PBS). Twenty-four hours later the medium was replaced by
the same medium plus ascorbic acid (50 ytg ml-'), P-amino-
propionitrile (50 Ag ml-') and 21iCi ml-' [2,3-3H]proline for
the final 24 h of culture. The antineoplastic agents and TGFP
were added during the labelling period.
After the labelling period the cells and medium were
scraped from the wells and the wells were washed twice with
1 ml of 50 mM Tris-HCl pH 7.6 containing 25 mM ethylene-
diaminetetraacetic acid (EDTA), 10 mM N-ethylmaleimide
(NEM), 1 mM phenylmethylsulfonylfluoride (PMSF) and
1 mM proline. The wash solution was added to the suspen-
sion which contained cells and medium. The final suspension
was freeze/thawed three times and the proteins were pre-
cipitated with trichloroacetic acid (TCA; final concentration
10%). The radioactive protein was separated from free
[3H]proline by repeated (3 x) washes with 5% TCA contain-
ing 1 mM proline at 4'C.
The final sediment was dissolved in 0.75 ml 0.2 M NaOH
and neutralised by the addition of 0.3 ml I M HEPES and
0.3 ml 0.15 M HCI. Aliquots from this solution (0.1 ml) were
counted to determine the incorporation in total protein. In
order to determine proline incorporation into collagen 0.2 ml
50 mM Tris-HCl, pH 7.6, containing 100 mM CaC12 and
0.1 ml collagenase (chromatographically purified on a G200
gel filtration column) were added to a 0.5 ml aliquot of the
solubilised sample and the mixture was incubated for 5 h at
37°C. The digestion was terminated by the addition of TCA
and tannic acid up to final concentrations of 0.6 M and
3 mM, respectively. After centrifugation (Omin; 14.500g) a
1.0 ml aliquot of the supernatant was counted in a liquid
scintillation analyser. The same procedure was followed with-
out the addition of collagenase. Subtraction of the counts
released in this blank incubation from those released in the
presence of collagenase yielded the collagen specific incor-
poration (collagenase-digestible protein CDP), representing
collagen synthesis. Subtraction of the radioactivity in the
CDP fraction from that in total protein yields the incorpora-
tion into non-collagenous protein (NCP). Incorporation into
CDP and NCP is quantified per well.
The relative collagen synthesis (RCS) was calculated with
the formula (Peterkofsky et al., 1981) that takes into account
the enrichment of proline in collagen compared to other
proteins:
% relative collagen synthesis =
CDP x 100%
(NCP x 5.4) + CDP
For each experimental condition, one 6-well culture plate was
used: four wells for the actual measurement of [3H]proline
incorporation and two wells for a cell count at the completion
of the incubation period.
Differences between control and drug-treated cultures were
tested for significance using a two-sided Wilcoxon test.
Results
Incubation with bleomycin or cisplatin resulted in a marked,
dose-dependent inhibition of DNA synthesis in actively divid-
ing cultures of skin fibroblasts in the logarithmiL growth phase
(Figure 1); a 50% inhibition was noted in the concentration
range of ± 17,UM. 5-Fluorouracil, even at the highest concen-
tration used, did not reduce proliferation. In order to exclude
drug effects on growth, further experiments were performed
with cultures of confluent, non-dividing fibroblasts. Under
these conditions, the addition of antineoplastic agent during
the final 24h of incubation did not significantly affect the
number of viable cells present.
Table I gives the average values for collagen synthesis in
both fibroblast strains. Incubation under serum-free conditions
reduced collagen synthesis. In skin fibroblasts the synthesis of
non-collagenous protein was reduced to a lesser extent and
therefore the relative collagen synthesis was also inhibited. In
colon fibroblasts the opposite was true.
The effect of each compound on fibroblast collagen syn-
thesis was examined for four concentrations (0.1, 1, 10 and
50 ,.M) and in cells cultured both in the absence and presence
of serum. Figure 2 shows the effects on colon fibroblasts
cultured in the presence of serum. Bleomycin and 5-fluor-
ouracil did not significantly affect collagen synthesis. The
higher concentrations of cisplatin strongly inhibited the incor-
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Figure 1 Effect of antineoplastic agents on proliferation of skin
fibroblasts. The average of six measurements is given as percen-
tage of [3H]thymidine incorporation in the absence of any agent.
Triangles: 5-fluorouracil; circles: cisplatin; squares: bleomycin.
Table I Collagen synthesis in human fibroblasts
Skinfibroblasts d.p.m. CDP/well %RCS
10% serum 27299± 7299 3.09±0.49
no serum 7194± 2979 1.30±0.69
Colonfibroblasts
10% serum 56730± 5904 2.22±0.06
no serum 20842±589 3.27±0.44
Synthesis was measured in both cell lines cultured in the presence or
absence of foetal calf serum. Result are given for both absolute (as
d.p.m. CDP/well) and relative (as %RCS) collagen synthesis. Data
represent average values±s.d. from five separate experiments.CYTOSTATICS AND COLLAGEN SYNTHESIS 547
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Figure 2 Effect of antineoplastic agents on collagen synthesis in
colon fibroblasts, measured in the presence of serum. Results are
given for the absolute a, and relative b, collagen synthesis and
expressed as average value, relative to synthesis in control cul-
tures, ±s.d. (four cultures). * denotes a significant (P < 0.05,
two-sided Wilcoxon test) difference between experimental and
control cultures.
poration of [3H]proline into the CDP fraction; the fact that
this inhibition was relatively specific for collagen is evident
from the fact that the relative collagen synthesis was also
significantly reduced, although to a somewhat lesser extent.
Figure 3 depicts the effects on skin fibroblasts. Here, bleo-
mycin inhibited the absolute collagen synthesis in a dose-
dependent manner. However, this effect appeared to be hardly
specific for collagen since the relative collagen synthesis was
reduced significantly only at the highest concentration tested.
Cisplatin induced inhibition only if added in a concentration
of 50 pM, but this appeared to be a general effect on protein
synthesis since the relative collagen synthesis remained essen-
tially unchanged. Again, addition of 5-fluorouracil had no
effect whatsoever.
The preceding data were obtained from cultures grown in
the presence of serum. If cells were grown without serum,
mostly similar results were obtained. In Table II the effects of
the highest concentrations (50I1M) of antineoplastic agents
used under both conditions are summarised. The data given
for colon and skin fibroblasts cultured with 10% serum have
been taken from Figures 2 and 3, respectively. In general,
effects were qualitatively similar though sometimes quanti-
tatively different. For instance, cisplatin inhibited the absolute
collagen synthesis in colon fibroblasts by 85% if cells were
grown with serum and by 41% if cells were grown without
serum. The only case where the different conditions resulted in
opposite effects was when skin fibroblasts were incubated with
bleomycin. Here, the relative collagen synthesis was reduced in
cells grown with serum and increased in cells grown without
serum.
TGFP promotes collagen synthesis and we have investigated
if this enhanced synthetic activity would be more susceptible to
inhibition by antineoplastic agents than the basal activity.
Since TGFP stimulation is more pronounced if cells, partic-
ularly colon fibroblasts, are cultured under serum-free condi-
tions[12] we used such conditions to study the effects of
antineoplastic drugs on TGFI-enhanced synthesis. Table III
shows that, if no TGF,B was present, neither of the drugs,
added at a 1 tIM concentration, significantly inhibited collagen
synthesis in both cell lines. The same was true if colon fibro-
Bleomycin Cisplatin 5-Fluorouracil
Figure 3 Effect of antineoplastic agents on collagen synthesis in
skin fibroblasts, measured in the presence of serum. See legend to
Figure 2.
Table II A comparison of the effects of antineoplastic agents on
collagen synthesis in fibroblasts, cultured in the presence or absence of
serum
Skinfibroblasts Colonfibroblasts
no serum 10% serum no serum 10% serum
CDP/well
control 100±3 380± 15 100±20 270±59
bleomycin 64±5a 163± 15a 80±31 216± 14
cisplatin 43 12a 171 ±Iga 59±4a 40±Sa
5-FU I1I 6a 353± 19 101 ± 16 221 ±40
RCS
control 100±2 240±7 100+8 68±3
bleomycin 115± ga 199±l0a 89± 8 70±2
cisplatin 96± 10 202± 17 76± 4a 31 ± 2a
5-FU 120± 8a 250± 10 103±9 64± 1
Results are given for absolute (as d.p.m. CDP/well) and relative (as
%RCS)collagen synthesis. The values measured in controls cultured in
the absence of serum are taken as 100%. Outcome of addition of
antineoplastic agents (at a 50jM concentration) is expressed as
percentile values with regard to the appropriate control cultures. Data
representaveragevalues(±s.d.)offourcultures. aSignificant (P < 0.05,
two-sided Wilcoxon) difference with matching controls.
blasts were supplemented with TGFP for the final 24 h of
culture. However, if TGFP was added to cultures of skin
fibroblasts all three compounds, at a 1 JLM concentration,
significantly inhibited the stimulated collagen synthesis. The
effect is demonstrated further in Figure 4. Whilst cisplatin only
inhibited basal collagen synthesis at concentrations higher than
10 DiM, TGF,B-induced collagen synthesis was already inhibited
significantly at a concentration of 0.1 tLM. Likewise, 5-
fluorouracil was without effect on basal collagen synthesis but
reduced TGFI3-induced collagen synthesis to basal levels from
a concentration of 1 tiM upwards.
Discussion
The contention that antineoplastic agents, if given in the
perioperative period, are a threat to uncomplicated wound548 T. HENDRIKS et al.
Table III A comparison of the effects of antineoplastic agents on
collagen synthesis in fibroblasts, cultured in the presence or absence of
TGFP
Skinfibroblasts Colonfibroblasts
-TGFI; +TGFp -TGFJP + TGFp
CDP/well
control 100±3 221 10 100±20 167± 18
bleomycin 105±8 183 15a 130± 13 164±40
cisplatin 93 ±9 138 15a 90± 14 139±26
5-FU 164±35 126±15a 116±27 162± 12
RCS
control 100±2 198±8 100±5 126±5
bleomycin 107± 5a 220± 18a 106±4 130±15
cisplatin 11 I± 2a 179±4a 99±11 119±9
5-FU 138±20 188±28 104± 19 131 ±4
Cells were cultured in the absence or presence ofTGFP (5 ng ml-')
without serum. Results are given forabsolute (as d.p.m. CDP/well) and
relative (as %RCS) collagen synthesis. The values measured in controls
cultured in the absence of TGFP are taken as 100%. Outcome of
addition ofantineoplastic agents (at a 1 tlM concentration) is expressed
as percentile values with regard to the appropriate control cultures.
Data represent average values (±s.d.) of four cultures. aSignificant
(P < 0.05, two-sided Wilcoxon) differences with matching controls.
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Figure 4 Effect of cisplatin a, and 5-fluorouracil b, on basal and
TGFP-stimulated collagen synthesis in skin fibroblasts. Results
are given for the absolute collagen synthesis, measured in the
absence of serum and either in the absence or presence of 5 ng
ml-' TGFP, and expressed as average value, relative to control
cultures without TGFP, ± s.d. (four cultures). * denotes a signi-
ficant (P <0.05, two-sided Wilcoxon test) difference between cul-
tures plus and minus antineoplastic agent.
healing appears to be accepted almost universally. Although
relevant clinical data are rare and fail to support this concept,
there exists a volume of experimental studies on the subject
which indeed demonstrates the potential for such a deleterious
effect. As a consequence, cancer chemotherapy has typically
been delayed for several weeks after surgical excisions of
tumours and the feasibility of perioperative treatment remains
at doubt, even as the indications for its use appear sound
(Cunliffe & Sugarbaker, 1989). Therefore, research into the
effects of the various antineoplastic agents on primary pro-
cesses of the healing sequence is much needed in order to
further assess their suitability for perioperative application.
Fibroblast collagen synthesis is crucial to the development
ofwound strength. Antineoplastic agents could interfere in this
process in several ways. For instance, they could prevent the
release of fibroblast-chemotactic mediators from platelets and
macrophages (by suppressing the numbers of these cells) or
inhibit fibroblast proliferation. In addition, they could interfere
directly with fibroblast collagen synthesis. With regard to this
last possibility, not much is known about the effect of drugs
which are commonly used today, with the possible exception
of adriamycin. The detrimental effects of this compound in
experimental models are severe and undisputed: it lowers
wound strength and collagen accumulation (Lawrence et al.,
1986a). Although it was shown recently that adriamycin
induces decreased gene expression for type I collagen in skin
wounds of rats (Salomon et al., 1990), it has also been
reported to reduce the synthesis of hydroxyproline in human
skin fibroblasts by inhibiting prolyl hydroxylase activity
(Sasaki et al., 1987).
No such equivocal data exist for 5-fluorouracil, which drug
remains the cornerstone for chemotherapy of colorectal cancer
(Grem, 1991). While earlier reports shown impaired healing of
experimental intestinal anastomoses (Goldman et al., 1969;
Morris, 1979), more recent data fail to support a detrimental
effect (Hillan et al., 1988). We have found that 5-fluororacil,
administered intravenously or intraperitoneally once a day
during the first 3 days after operation, did not affect strength
or hydroxyproline content of intestinal anastomoses (de
Waard et al., manuscript in preparation).
Very recently Graf et al. (1992) reported decreased strength
of experimental colonic anastomoses after 7 days of intra-
peritoneal administration of 5-fluorouracil. As with all experi-
mental studies on the effects ofantineoplastic agents on wound
repair, results remain difficult to compare because variations in
protocol, e.g. dose and mode and time ofadministration of the
drug. 5-Fluorouracil is one of the few drugs that has been used
clinically in the perioperative period: no evidence was found
for increased anastomotic leakage after intravenous infusion
commencing during or immediately after operation (Taylor et
al., 1985; Klausner et al., 1986; Wolmark et al., 1990). One
clear result from the present experiments is that 5-fluorouracil
does not directly affect collagen synthesis in colon fibroblasts,
under any of the conditions tested. In addition, fibroblast
proliferation appeared to be refractory to the presence of the
drug. Inhibitory effects on proliferation of human fibroblasts
have been reported after longer incubations with 5-fluorouracil
(Wong et al., 1991). Still, we believe that our results support
the idea, which may be inferred from the clinical data avail-
able, that it should be safe to administer 5-fluorouracil imme-
diately after resection of a colorectal cancer.
Cisplastin, which is often used together with 5-fluorouracil
as adjuvant in the treatment of gastrointestinal tumours, is
reported to impair the development ofstrength in rat intestinal
anastomoses (Engelmann et al., 1983). klthough no data on
wound collagen content were supplied, our results show that
cisplatin can strongly and, to a large extent, specifically sup-
press collagen synthetic capacity in colon fibroblasts. Thus, the
evidence available cautions against the peri-operative use of
cisplatin.
We have also tested the effects of bleomycin since this drug
was included in the mixture administered in vivo in our pre-
vious experiments with rat intestinal anastomoses (de Roy van
Zuidewijn et al., 1986, 1991; Martens et al., 1992a). No
experiments have been reported on the effects of bleomycin
alone on intestinal healing. Collagen synthesis in colon fibro-
blasts remains unaffected by bleomycin, in contrast to skin
fibroblast where bleomycin induced a significant, though not
very specific, inhibition. This appears in agreement with earlier
results which show that bleomycin, at concentrations around
I ylM, though increasing the amount of procollagen mRNA in
the cell layer (Sterling et al., 1983), eventually induces an
inhibition of the synthesis of collagenous protein in the
medium because it is being rapidly degraded intracellularly and
extracellularly (Sterling et al., 1982). It should be emphasised
that the method employed in our experiments measures the net
accumulation ofcollagen in cell layer plus medium, the bulk ofCYTOSTATICS AND COLLAGEN SYNTHESIS 549
the collagen being present in the medium.
The latter results illustrate the differences observed by us
between colon and skin fibroblasts. Both absolute and relative
collagen synthesis in colon fibroblasts remains unaffected by
bleomycin while being inhibited in skin fibroblasts. Cisplatin
strongly suppresses absolute and relative collagen synthesis in
colon cells, while only affecting the absolute synthesis in skin
fibroblasts at the highest concentration used. These results
further extend our recent findings (Martens et al., in press)
that fibroblasts from both tissues exhibit divergent reactions to
various stimuli and therefore may cause wounds in skin and
intestine to behave differently under certain conditions.
It is becoming increasingly clear that TGFPi plays an impor-
tant regulatory role in wound healing (Cromack et al., 1987;
Kane et al., 1991). It has been shown that the expression of
mRNA for TGF,B is decreased in adriamycin-impaired skin
wounds (Salomon et al., 1990) and that exogenous TGFP
reverses the adriamycin-induced inhibition ofcollagen accumu-
lation in wound chambers (Lawrence et al., 1986b). Therefore,
it is interesting to observe that, ifthe collagen synthesis in skin
fibroblast is stimulated by addition of TGF,B to the cultures,
the additional activity is significantly inhibited by concentra-
tions ofantineoplastic agents which are much lower than those
necessary to inhibit the basal synthetic activity. Possibly, this
effect of antineoplastic agents on TGFI-elicited synthetic
activity has far more direct implications for the process of
wound healing than their effects on basal fibroblast activity.
Further experiments are needed to elucidate the mechanism of
this effect, e.g. regarding the question if it is mediated at the
transcriptional or at the post-transcriptional level. The fact
that TGFP-stimulated collagen synthesis in colon fibroblasts
remains unaffected by 5-fluorouracil would then give addi-
tional weight to the argument that this drug is relatively
harmless to colonic wound healing.
Altogether, the present data show that antineoplastic agents
can have diverse effects on fibroblast collagen synthesis. If one
wants to assess possible effects of a drug on tissue wound
repair by measuring its effects on fibroblast collagen synthesis,
it appears indicated to use fibroblasts derived from that partic-
ular tissue and to measure also after stimulation by TGFP . It
should be emphasised that we do not propose (as yet) to use
such an assay as a predictor of wound healing effects in vivo.
Although we certainly believe the outcome to be pertinent to
the repair sequence, at this time they can only be used to
explain, and not to replace, observations made in vivo.
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